Member Info for Bluebelly

Y-Alam:
i agree with your comments - Accustem has bee a total Fuster cluck!
I was just calling out DCR on the 12 years from now comment.
I won't be hear in 12 years, unless it becomes dividend paying & I doubt that. This will be bought out Lock, Stock & Barrel or through Individual treatments.
At 63p there has been no shareholder value created for LTH since Feb 15. By 2027 the 12 years will be up and they should be in a good place. though

BB

DCR.
Does the clock reset when the price goes low?
You were a positive poster last year when posting, similar comments.
Do you see a large positive re-rate on successful proof of concept for Foralumab.
Even Zack's research note gave 2027/28 time frame for the drug at market. What about a partner in Asia for Miliclib. Each part of the pipeline is targeting areas that could add $b's to the mcap.
I'm personally happy with a four/five bagger from here in 12/24 months, with Accustem separated.

BB

Was the 2 for 1 ratio just for the Nasdaq listing?
That would make it slightly better, but I fear it's still 2 accustem for 1 ACMSY.

BB

ACMSY shows it's at $0.30 (25% down) about 10p/share.
So a combined price of about 75p, 1 year on from being under valued when combined.
May be next year.

BB

I did first thing. We had 20 plus share trades by just gone 08:00. Thought it was a glitch, but they were still there later.

BB

I'm guessing we'll have to see if Accustem is trading in the US properly on OTC:PK's. It would comfirm the split is complete and all info would come via Accustem website or SEC news release.
Tils SP is the same as 6th May 20 pricing last year before the Demerger RNS on 22nd may 20.

BB

This is the kind of information that could have been put out by TILS to assist shareholders with what is actually going on. As opposed to a brief set of bullet points and dates leaving lots of questions.
Posted by: JWandS
https://ir.gwpharm.com/static-files/284adba8-a4ba-40a0-90d8-7d5f002dd682

There is also a post by $ilverlight at 16:32 16/7/21. A reply from HL @ 15:32 on Friday stating Accustem will trade on the Nasdaq as of next week and will become dual listed end of 2021.

Download the telegram app/desktop and join the Tils & Accustem groups, links posted by Paulmspencer recently.
https://twitter.com/AshfordPlumber/status/1414956509641969664?s=19
https://twitter.com/AshfordPlumber/status/1414929350688919567?s=19

BB

-34% presently
https://www.cnbc.com/quotes/ACMSY?qsearchterm=acmsy

BB

It's a shame lots of people topped up in the 70p, 80p & 90p areas.

BB

II don't allow US OTC stocks to be held in an ISA, not sure if we can keep Accustem entitlement (x2 of the ADR's) there until they are trading on the Nasdaq. I will be disappointed if there are tax implications from this.
£30K down in an ISA on 60k TILS and 30,000 Accustem transferred to trading account and subject to CGT.
Sporty & Shirazkhan with £100,000's in shares. Court Action could be a outcome, as demerger stated FTSE listing and now there are millions of shares that cannot be held in tax free wrappers as RNS'd prior to Ex entitlement date.
A poor show that continues to disappoint

By the way, I'm still confident that TILS will recover my losses and more. However the company has not covered itself in glory from a Uk investors perspective.

BB

'Acc can be held in both ISA & SIPP'.
Only if they allow trading in OTC Pinks, I believe.

BB

Any one who knew that TLSA ex div date was early July could have sold their TILS holding and bought TLSA to double up on their Accustem entitlement.
GC could have transferred his holding from TILS to TLSA ADR's and still held the same percentage, so no requirement to notify the market. His 66m shares would become 132m Accustem, but issued shares would have to increase by 66m to 260m. Confusing.
I hope that is not the case, obviously.

BB

If you hold TLSA ADR's you get 1 Acustem ADR's per TLSA ADR ( Which is equal to 2 Accustem shares)
If you held TILS you get you get 1 Accustem share per TILS share. If you get 1000 shares in Accustem they will equal 500 Accustem ADR's.

BB

It states a new 52wk high of $1.00
Todays low $0.01

BB

Casa
I don't believe they're trading yet. Maybe testing prior to Monday.
The price has been changing 20 to 40 cents.
https://www.cnbc.com/quotes/ACMSY

BB

220k shares traded at a total cost of £150k.
If we ever get to trade Accustem, I may well sell them and buy TILS at this price.

BB

It would have to trade around $1.38 for 50p/tils share entitlement.
I don't know what to expect now.
Trading at a 52wk low (6th May 20).
Pharma's are out of favour but expected to bounce back in H2/21.

BB

Thanks SJ1, that's interesting to know.

BB

Levs: We are too far away from any expected good news.
That's the time people lose out, don't get caught out by the unexpected if you see value at 70p.
A quick spike up and some recent sellers won't buy back, they'll wait for the fall, which doesn't come. Then 150p is suddenly the floor.

BB - Also £30k down minus Accustem value

I think there will be a queue to sell in the early days, due to the amount of share dealing platforms that need to sell to return money to TILS holders.
After that the liquidity will decided on the amount of interest in Acustem. From previous experience, you will place an order with your platform and wait for it to be executed.

On another note, I'm hoping my Accustem showing in II will divide by two and show the ticker code: ACMSY

BB